English
Svenska
About Us
About Us
This is Calliditas
Vision and Strategy
Board of Directors
Management Team
Our History
Corporate Responsibility
Expanded Access Policy
Careers
Science
Science
Our Pipeline
Nefecon (ex-US Markets)
Setanaxib – NOX Platform
Orphan drugs
Our Product
Governance
Governance
Corporate Governance
Corporate Governance Reports
Corporate Structure
General Meeting
Annual general meeting 2022
General meetings
Nomination Committee
Nomination committees
Board and Committees
Board of Directors
Board fees
Work of the Board of Directors
Committees
Management
Management team
Remuneration
Internal Control and Risk Management
Auditor
Articles of Association
Investors
Investors
The Share
Trading information
Ownership structure
Share capital development
Dividend policy
Analyst coverage
Financial Reports and Presentations
SEC Filings
Press Releases
Financial Calendar
IR Calendar
Subscribe
Contacts
Investor FAQs
Media
Media
Press releases
Calliditas in Media
Calliditas Media Kit
TARPEYO Media Kit (US audience only)
Subscribe
Contacts
Contact Us
Contact Us
Offices
Partnerships and Inquires
Investor Relations
Media
Medical Inquiries
Svenska
Search for:
Search
Calliditas in Media
All years
2022
2021
Jun 16, 2022
Calliditas wins ‘Company of the Year’ at the European Mediscience Awards 2022
Read more
Sep 27, 2021
Calliditas nominated for Breakthrough of the Year Award, Best Communication Award, and Chief Executive of the Year Award at the 2021 European Mediscience Awards
Read more
Feb 2, 2021
How Sweden’s Calliditas Built Up Its US Presence And Development Portfolio
Executive Summary Interview: delivering on its US business strategy during the COVID-19 pandemic has required a focus on communication, according to Calliditas CEO Renee...
Read more
